Non-invasive prenatal testing (NIPT) In Singapore

Pregnancy brings joy and anticipation, but also natural concerns about your baby’s health. Non-invasive prenatal testing (NIPT) offers expectant parents peace of mind through a simple blood test that screens for common chromosomal conditions. This screening method has transformed prenatal care in Singapore, providing valuable information about your baby’s genetic health without any risk to your pregnancy. Understanding NIPT helps you make informed decisions about prenatal screening options available to you.

Dr. Harvard Lin

Obstetrician & Gynaecologist

MBBS (SG)|MRCOG (UK)|MMed (OBGYN) (SG)

Make an Enquiry

Suitability Methods Process Results Benefits Considerations Cost FAQ Conclusion

What is Non-Invasive Prenatal Testing (NIPT)?

Non-invasive prenatal testing is a screening method that analyses cell-free fetal DNA circulating in maternal blood to assess the risk of specific chromosomal conditions. During pregnancy, small fragments of your baby’s DNA naturally cross the placenta and enter your bloodstream. NIPT examines these DNA fragments to screen for conditions such as Down syndrome (trisomy 21), Edwards syndrome (trisomy 18), and Patau syndrome (trisomy 13).

This screening test requires only a standard blood draw from the mother’s arm, making it entirely safe for both mother and baby. Unlike invasive procedures such as amniocentesis or chorionic villus sampling (CVS), NIPT carries no risk of miscarriage. The test can be performed as early as 10 weeks of pregnancy and provides results within 7-10 days.

NIPT offers higher accuracy rates than traditional first-trimester screening methods. While it screens for common chromosomal conditions, NIPT is a screening test, not a diagnostic test, meaning abnormal results require confirmation through diagnostic testing.

Ideal Candidates

All pregnant women from 10 weeks of gestation onwards
Women aged 35 years or older at delivery
Those with abnormal ultrasound findings suggesting increased risk
Previous pregnancy affected by chromosomal abnormality
Positive results from traditional screening tests
Parents seeking additional reassurance about chromosomal health
Those who prefer to avoid invasive testing initially
Multiple pregnancies (twins or triplets)

Contraindications

Gestational age less than 10 weeks
Active cancer or recent cancer treatment
Recent blood transfusion (within 12 months)
Bone marrow or organ transplant recipients
Certain chromosomal conditions in the mother
Vanishing twin syndrome diagnosed in the current pregnancy

A professional assessment by our obstetrician determines whether NIPT is suitable for your specific situation. Your medical history, pregnancy circumstances, and personal preferences all play a role in this decision. Some women may benefit from genetic counselling before deciding on prenatal screening options.

Testing Methods & Technology

Cell-Free DNA Analysis

The primary technology behind NIPT involves analysing cell-free fetal DNA (cfDNA) in maternal plasma. This DNA originates from placental cells and typically comprises 10-15% of the total cell-free DNA in maternal blood after 10 weeks of pregnancy. Laboratory techniques separate and analyse these DNA fragments to detect chromosomal abnormalities.

Screening Capabilities

Current NIPT screens for multiple conditions beyond the common trisomies. Basic panels include trisomy 21, 18, and 13, while expanded panels may screen for sex chromosome abnormalities and select microdeletions. Some tests also determine fetal sex with over 99% accuracy, though this information remains optional.

Laboratory Processing

Specialised laboratories use next-generation sequencing or microarray technology to analyse the DNA samples. These techniques count DNA fragments from specific chromosomes, comparing ratios to identify potential abnormalities. Quality control measures ensure sufficient fetal DNA fraction for accurate results.

Wondering which NIPT panel suits your needs?

Our obstetrician will assess your specific situation and recommend the most suitable screening options for you.

Book Appointment

The Testing Process

Pre-Test Preparation

Before your NIPT appointment, no special preparation is required. You can eat and drink normally, and the test can be performed at any time of day. Our obstetrician will discuss the test’s capabilities and limitations, ensuring you understand what conditions are screened and what results mean. Consent forms outline the testing process and possible outcomes.

Some clinics recommend scheduling NIPT in conjunction with your routine prenatal appointments for added convenience. Bring your identification and any relevant medical records. If you’ve had ultrasounds, bring those reports as they help correlate findings with NIPT results.

During the Procedure

The NIPT procedure is similar to a standard blood draw. Approximately 10-20ml of blood from a vein in your arm, typically using one or two collection tubes. The entire process takes less than five minutes.

After collection, samples are carefully labelled and sent to specialised laboratories for processing. Some clinics use international laboratories with established quality standards, while others utilise local facilities. Our healthcare provider will explain where your sample will be processed and the expected turnaround times.

Immediate Post-Test

Following blood collection, you can resume normal activities immediately. No recovery time or special precautions are needed. Apply pressure to the puncture site for a minute to prevent bruising. The results will be delivered – typically through a follow-up appointment, where our obstetrician will explain the findings to you.

Most women experience no side effects from NIPT. Rarely, minor bruising may occur at the site of the blood draw. The waiting period for results can cause anxiety for some parents, which is entirely normal. Our healthcare team remains available to address any concerns you may have during this time.

Understanding Your Results

Result Categories

NIPT results typically fall into three categories: low risk, high risk, or inconclusive. Low-risk results indicate a very low probability of the tested conditions, providing reassurance to most parents. These results have high negative predictive values, meaning a low-risk result strongly suggests your baby doesn’t have the screened conditions.

High-risk results indicate an increased likelihood of a chromosomal condition, but don’t provide a definitive diagnosis. The positive predictive value varies by condition and maternal age. For example, NIPT’s accuracy for Down syndrome exceeds 99%, while accuracy for rarer conditions may be lower. High-risk results always require confirmation through diagnostic testing.

Inconclusive Results

Approximately 1-5% of NIPT attempts yield inconclusive results, usually due to insufficient fetal DNA fraction. Factors contributing to this include early gestational age, high maternal weight, or the use of certain medications. Our obstetrician will discuss options, which may consist of repeating the test or proceeding to alternative screening methods.

Follow-up Care

Low-risk results typically require no additional testing beyond routine prenatal care. High-risk results prompt genetic counselling and discussion of diagnostic testing options like amniocentesis or CVS. These invasive tests provide definitive diagnoses but carry a risk of small miscarriage. Our obstetrician guides you through these decisions, taking into account your values and circumstances.

Our obstetrician provides comprehensive counselling to help you understand your NIPT results and the next steps.

Schedule your consultation to learn more about prenatal screening options.

Schedule Consultation

Benefits of Non-Invasive Prenatal Testing

NIPT offers numerous advantages over traditional screening methods. The test’s high accuracy rates provide reliable information about common chromosomal conditions, with detection rates exceeding 99% for Down syndrome. This accuracy significantly reduces false-positive rates compared to conventional first-trimester screening, resulting in fewer women undergoing unnecessary invasive testing.

Early testing capability, available from 10 weeks, enables earlier decision-making and planning. Parents gain valuable time to prepare emotionally and practically if results indicate potential concerns. The non-invasive nature eliminates the miscarriage risk associated with amniocentesis or CVS, making it an attractive option for women who want genetic information without endangering their pregnancy.

Beyond medical benefits, NIPT provides psychological advantages. Many parents report reduced anxiety after receiving low-risk results. Even when results indicate a higher risk, early knowledge allows time for education, building a support network, and informed decision-making about pregnancy management. The option to learn fetal sex early adds another dimension for families eager for this information.

Considerations

Screening vs Diagnostic Testing

Understanding the role of NIPT as a screening test remains crucial. Unlike diagnostic tests, NIPT cannot definitively confirm or rule out chromosomal conditions. The test estimates risk levels based on DNA analysis; however, various factors can impact accuracy. False positives, though rare, do occur, emphasising why abnormal results require diagnostic confirmation.

NIPT doesn’t screen for all genetic conditions or birth defects. Many genetic disorders, structural abnormalities, and neural tube defects aren’t detectable through NIPT. Comprehensive prenatal care includes ultrasound examinations and other screening tests to assess fetal development beyond chromosomal health.

Limitations & Considerations

It is essential to recognise that NIPT is a screening test, not a diagnostic test. This means it can estimate the likelihood of certain chromosomal conditions but cannot confirm them with certainty. A high-risk result should always be followed up with diagnostic testing such as amniocentesis or chorionic villus sampling (CVS). In contrast, a low-risk result does not entirely rule out all genetic conditions.

Another consideration is that NIPT does not detect every possible genetic condition or birth defect. The test focuses mainly on common trisomies such as Down syndrome, Edwards syndrome, and Patau syndrome. Other genetic disorders, structural abnormalities, and neural tube defects may not be identified, which is why NIPT is usually combined with ultrasound scans and other prenatal assessments for a more complete picture of fetal development.

The accuracy of NIPT can also be affected by certain factors. These include very early gestational age, low levels of fetal DNA in the blood sample, or specific maternal health conditions. Situations such as vanishing twin syndrome, where one twin stops developing early in pregnancy, may also influence the results. In these cases, our doctor may recommend repeating the test or considering alternative options.

Finally, if a high-risk result is obtained, the next step often involves genetic counselling and discussions about further testing. This process can be emotionally challenging, so it is important to approach NIPT with an understanding of both its strengths and its limitations. Professional guidance ensures you receive appropriate support and clear explanations at every stage.

Cost Considerations

The costs of non-invasive prenatal testing in Singapore vary depending on the testing panel selected and the laboratory used. Basic panels screening for common trisomies typically cost less than expanded panels, including microdeletions and sex chromosome abnormalities. International laboratory processing may incur additional fees compared to local options.

Factors affecting cost include the comprehensiveness of genetic counselling, result interpretation services, and follow-up consultations. Some clinics offer package pricing combining NIPT with routine prenatal visits. While most insurance plans don’t cover NIPT as it’s considered elective screening, some providers offer payment plans to improve accessibility.

When evaluating costs, consider the potential savings from avoiding unnecessary invasive procedures due to false-positive results from traditional screening. The value of early, accurate information for pregnancy planning and peace of mind also factors into the cost-benefit analysis. Our obstetrician can discuss pricing options and help determine the most appropriate testing approach within your budget.

Frequently Asked Questions (FAQ)

How accurate is NIPT compared to other prenatal screening tests?

NIPT demonstrates significantly higher accuracy than traditional first-trimester screening. For Down syndrome detection, NIPT achieves over 99% sensitivity with a false-positive rate of less than 0.1%. Traditional combined screening has approximately 85% sensitivity with a 5% false-positive rate. This improved accuracy means fewer women receive false-positive results requiring invasive follow-up testing. Accuracy varies by condition screened, with common trisomies showing higher accuracy than rare conditions.

Can NIPT replace the need for ultrasound scans during pregnancy?

No, NIPT cannot replace ultrasound examinations. While NIPT screens for specific chromosomal conditions, ultrasounds assess fetal anatomy, growth, placental position, and amniotic fluid levels. Many birth defects and pregnancy complications aren’t detectable through NIPT but may be identified via ultrasound. Both tests serve complementary roles in comprehensive prenatal care. Our obstetrician will recommend scheduling an appropriate ultrasound in conjunction with NIPT.

What happens if I receive a high-risk NIPT result?

High-risk results require genetic counselling and discussion of diagnostic testing options. Our obstetrician will explain the specific condition flagged, its implications, and the probability of accurate positive results based on your circumstances. Diagnostic procedures like amniocentesis or CVS can confirm or rule out the condition. Some parents opt for diagnostic testing to obtain definitive answers, while others may decline based on their personal values. Support services help navigate this challenging situation.

Is NIPT safe for twin pregnancies?

Yes, NIPT is safe for twin pregnancies as it only requires maternal blood sampling. The test can determine if there is a high risk of chromosomal conditions, but it cannot identify which twin might be affected. Fetal fraction requirements are higher for accurate results in twins. Our obstetrician will discuss these limitations and may recommend additional monitoring or testing strategies specific to multiple pregnancies.

How early can NIPT detect the baby’s gender?

NIPT can accurately determine fetal sex from 10 weeks of pregnancy, with accuracy exceeding 99%. This early detection surpasses ultrasound, which typically determines sex around 18-20 weeks. Gender determination through NIPT analyses Y chromosome presence – its detection indicates a male fetus, while absence suggests female. Please note that gender determination is optional; you can choose to receive this information or keep it confidential until delivery.

Can NIPT detect all genetic conditions?

No, NIPT screens for specific chromosomal conditions, primarily trisomies 21, 18, and 13. Expanded panels may include sex chromosome abnormalities and select microdeletions. NIPT doesn’t detect single-gene disorders, neural tube defects, or many structural abnormalities. The test covers conditions responsible for a significant portion of genetic abnormalities; however, it is not comprehensive. Our obstetrician will explain the conditions included in your chosen panel and discuss additional screening options if necessary.

Conclusion

Non-invasive prenatal testing represents a valuable advancement in prenatal screening, offering expectant parents in Singapore safe, accurate information about their baby’s chromosomal health. Through a simple blood test, NIPT provides insights that help guide pregnancy management and family planning decisions. While understanding its role as a screening tool remains important, NIPT’s high accuracy rates and zero risk to pregnancy make it an increasingly popular choice for prenatal care.

Ready to Take the Next Step?

If you’re considering non-invasive prenatal testing, our obstetrician can help you understand if it’s the right choice for your pregnancy. With experience in prenatal screening and diagnosis, we provide personalised care throughout your pregnancy journey.

Book Your Consultation Today

Dr. Harvard Lin

Obstetrician & Gynaecologist

MBBS (SG)|MRCOG (UK)|MMed (OBGYN) (SG)

Dr. Harvard Lin is renowned for his expertise in female pelvic medicine and reconstructive surgery.

Dr. Lin’s journey in medicine began at the prestigious National University of Singapore, where he earned his Bachelor of Medicine and Bachelor of Surgery (MBBS). His commitment to excellence led him to further his education by becoming a Member of the Royal College of Obstetricians and Gynaecologists (MRCOG) through the Royal College of Obstetricians and Gynaecologists in the United Kingdom. He also holds a Master of Medicine (Obstetrics and Gynaecology) from the National University of Singapore.

As the Chief Coordinator of Gynaecologic Services at the National University Health System (NUHS), Dr. Lin plays a pivotal role in ensuring the highest quality care for women’s health. His leadership is also evident in his position as the Deputy Clinical Director of Obstetrics and Gynaecology at NUHS, where he contributes to shaping gynaecologic practices and growth across the cluster including Ng Teng Fong Hospital, Alexandra Hospital and Jurong Medical Centre.

read full bio

Billing & Insurance